Detection of exposure related cortical responses by amphetamine using PCASL and pharmacokinetic/pharmacodynamic dose modeling
نویسندگان
چکیده
L. E. Nordin, T-Q. Li, J. Brogren, N. Sjögren, K. Hannesdottir, J. Wang, and P. Julin Diagnostic Medical Physics, Karolinska University Hospital, Huddinge, Stockholm, Sweden, Clinical Science, Intervention and Technology, Division of Medical Imaging and Technology, Karolinska Institute, Stockholm, Sweden, AstraZeneca R&D Neuroscience, Södertälje, Sweden, Neurology, UCLA, Los Angeles, CA, United States, Section for Brain Injury Rehabilitation, Department of Rehabilitation Medicine, Danderyd University Hospital, Karolinska Institutet, Stockholm, Sweden
منابع مشابه
A Bayesian approach for dose-escalation in a Phase I clinical trial incorporating pharmacodynamic endpoints.
Bayesian decision procedures have already been proposed for and implemented in Phase I dose-escalation studies in healthy volunteers. The procedures have been based on pharmacokinetic responses reflecting the concentration of the drug in blood plasma and are conducted to learn about the dose-response relationship while avoiding excessive concentrations. However, in many dose-escalation studies,...
متن کاملLisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of Efficacy
Lisdexamfetamine dimesylate (LDX) is a long-acting d-amphetamine prodrug used to treat attention-deficit/hyperactivity disorder (ADHD) in children, adolescents and adults. LDX is hydrolysed in the blood to yield d-amphetamine, and the pharmacokinetic profile of d-amphetamine following oral administration of LDX has a lower maximum plasma concentration (Cmax), extended time to Cmax (Tmax) and lo...
متن کاملThe pharmacokinetics and pharmacodynamics of monoclonal antibodies--mechanistic modeling applied to drug development.
The pharmacology of therapeutic monoclonal antibodies (mAbs) is complex and dependant on both the structure of the antibody and the physiological system that it targets. Patient exposure and responses to mAbs are also related to the structure and activity of mAbs. Furthermore, the pharmacokinetics and pharmacodynamics of mAbs are often inter-related. Pharmacokinetic and pharmacodynamic modeling...
متن کاملPharmacokinetic and pharmacodynamic modeling to determine the dose of ST-246 to protect against smallpox in humans.
Although smallpox has been eradicated, the United States government considers it a "material threat" and has funded the discovery and development of potential therapeutic compounds. As reported here, the human efficacious dose for one of these compounds, ST-246, was determined using efficacy studies in nonhuman primates (NHPs), together with pharmacokinetic and pharmacodynamic analysis that pre...
متن کاملPharmacokinetic/Pharmacodynamic Modeling of the PDE4 Inhibitor TAK‐648 in Type 2 Diabetes: Early Translational Approaches for Human Dose Prediction
TAK-648 is a PDE4 inhibitor with demonstrated preclinical antidiabetic properties. Our objective was to develop a translational pharmacokinetic/pharmacodynamic (PK/PD) model for human type 2 diabetes (T2D) dose prediction using HbA1c results from a db/db mouse study. Estimated parameters in combination with tPDE4i values calculated for the clinical roflumilast dose of 500 μg were used to transl...
متن کامل